Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Anal Canal Carcinoma × Platinum × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 14 Squamous Cell Carcinoma of Head and Neck 10 Small Cell Lung Carcinoma 9 Lung Neoplasms 8 Urinary Bladder Neoplasms 5 Oropharyngeal Neoplasms 5 Mouth Neoplasms 5 Laryngeal Neoplasms 5 Carcinoma 5 Uterine Cervical Neoplasms 4 Hypopharyngeal Neoplasms 4 Breast Neoplasms 4 Stomach Neoplasms 3 Nasopharyngeal Carcinoma 3 Adenocarcinoma of Lung 3 Vulvar Neoplasms 2 Triple Negative Breast Neoplasms 2 Salivary Gland Neoplasms 2 Recurrence 2 Paranasal Sinus Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Liver Neoplasms 2 Head and Neck Neoplasms 2 Fallopian Tube Neoplasms 2 Cholangiocarcinoma 2 Brain Neoplasms 2 Anus Neoplasms 2 Urethral Neoplasms 1 Ureteral Neoplasms 1

Interventions

Fluorouracil 5 Cisplatin 4 Radiotherapy 3 Magnetic Resonance Spectroscopy 3 Capecitabine 3 dehydroftorafur 2 Specimen Handling 2 Radiotherapy, Intensity-Modulated 2 Cetuximab 2 toripalimab 1 pembrolizumab 1 atezolizumab 1 Vaccines 1 Taxes 1 Radiosurgery 1 Radiation 1 Platinum 1 Paclitaxel 1 Nivolumab 1 Mitozytrex 1 Mitomycins 1 Mitomycin 1 Ipilimumab 1 Fluorodeoxyglucose F18 1 Docetaxel 1 Carboplatin 1 CTLA-4 Antigen 1 Biopsy 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02560298 2023-06-22

InterAACT

Eastern Cooperative Oncology Group

Phase 2 Unknown

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡